Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W P Petros

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Hematology/Oncology Clinics of North America|June 1, 1993
Role of cytokines in autologous bone marrow transplantationW P Peters, M Ross, J Vredenburgh, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Carboplatin pharmacokinetics in young children with brain tumorsM E Tonda, R L Heideman, W P Petros, et al.
Cancer Research|January 13, 2001
Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug releaseG Kong, G Anyarambhatla, W P Petros, et al.
Pharmacotherapy|July 1, 1997
A prospective, open-label study of single-dose ciprofloxacin absorption after chemotherapy in patients with malignancyW A Gattis, W P Petros, W W Pickard, et al.
Cancer Research|February 28, 2001
Intraneoplastic polymer-based delivery of cyclophosphamide for intratumoral bioconversion by a replicating oncolytic viral vectorT Ichikawa, W P Petros, S M Ludeman, et al.
Blood|September 1, 1992
Disposition of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving high-dose chemotherapy and autologous bone marrow supportW P Petros, J Rabinowitz, A R Stuart, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Pharmacokinetic and biotransformation studies of ormaplatin in conjunction with a phase I clinical trialW P Petros, S G Chaney, D C Smith, et al.
Pediatric Clinics of North America|October 1, 1989
Clinical pharmacology of cancer chemotherapy in childrenW E Evans, W P Petros, M V Relling, et al.
Pharmacotherapy|January 1, 1992
Variability in teniposide plasma protein binding is correlated with serum albumin concentrationsW P Petros, J H Rodman, M V Relling, et al.
Molecular Pharmacology|January 1, 1993
High-dose chemotherapy-induced platelet defect: inhibition of platelet signal transduction pathwaysL Karolak, A Chandra, W Khan, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Hematology/Oncology Clinics of North America|June 1, 1993
Role of cytokines in autologous bone marrow transplantationW P Peters, M Ross, J Vredenburgh, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Carboplatin pharmacokinetics in young children with brain tumorsM E Tonda, R L Heideman, W P Petros, et al.
Cancer Research|January 13, 2001
Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug releaseG Kong, G Anyarambhatla, W P Petros, et al.
Pharmacotherapy|July 1, 1997
A prospective, open-label study of single-dose ciprofloxacin absorption after chemotherapy in patients with malignancyW A Gattis, W P Petros, W W Pickard, et al.
Cancer Research|February 28, 2001
Intraneoplastic polymer-based delivery of cyclophosphamide for intratumoral bioconversion by a replicating oncolytic viral vectorT Ichikawa, W P Petros, S M Ludeman, et al.
Blood|September 1, 1992
Disposition of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving high-dose chemotherapy and autologous bone marrow supportW P Petros, J Rabinowitz, A R Stuart, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Pharmacokinetic and biotransformation studies of ormaplatin in conjunction with a phase I clinical trialW P Petros, S G Chaney, D C Smith, et al.
Pediatric Clinics of North America|October 1, 1989
Clinical pharmacology of cancer chemotherapy in childrenW E Evans, W P Petros, M V Relling, et al.
Pharmacotherapy|January 1, 1992
Variability in teniposide plasma protein binding is correlated with serum albumin concentrationsW P Petros, J H Rodman, M V Relling, et al.
Molecular Pharmacology|January 1, 1993
High-dose chemotherapy-induced platelet defect: inhibition of platelet signal transduction pathwaysL Karolak, A Chandra, W Khan, et al.
Pageof 5